Total Payments
$132,142
2024 Payments
$4,230
Companies
40
Transactions
858
Medicare Patients
9,054
Medicare Billing
$785,392
Payment Breakdown by Category
Other$85,350 (64.6%)
Food & Beverage$28,287 (21.4%)
Travel$10,336 (7.8%)
Consulting$8,150 (6.2%)
Education$19.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,350 | 32 | 64.6% |
| Food and Beverage | $28,287 | 789 | 21.4% |
| Travel and Lodging | $10,336 | 28 | 7.8% |
| Consulting Fee | $8,150 | 6 | 6.2% |
| Education | $19.03 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $42,019 | 107 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $28,406 | 137 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $16,243 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13,493 | 110 | $0 (2024) |
| Amgen Inc. | $12,191 | 96 | $0 (2024) |
| Medtronic Vascular, Inc. | $4,498 | 14 | $0 (2019) |
| Novo Nordisk Inc | $2,633 | 56 | $0 (2024) |
| Abbott Laboratories | $1,792 | 29 | $0 (2023) |
| Boston Scientific Corporation | $1,777 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,586 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,230 | 128 | Amgen Inc. ($535.63) |
| 2023 | $4,652 | 126 | Amgen Inc. ($840.13) |
| 2022 | $3,786 | 101 | Novo Nordisk Inc ($631.97) |
| 2021 | $3,368 | 92 | Novo Nordisk Inc ($807.49) |
| 2020 | $8,964 | 53 | AstraZeneca Pharmaceuticals LP ($8,155) |
| 2019 | $20,638 | 127 | Janssen Pharmaceuticals, Inc ($13,497) |
| 2018 | $49,444 | 133 | Novartis Pharmaceuticals Corporation ($13,134) |
| 2017 | $37,060 | 98 | Janssen Pharmaceuticals, Inc ($13,595) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $116.58 | General |
| 12/11/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $120.54 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
| 12/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/04/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Genetic Disease | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $120.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Renal Denervation System | ||||||
| 11/16/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Not Applicable | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Obesity | ||||||
| 11/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,450 | 2,948 | $789,609 | $195,306 |
| 2022 | 19 | 2,367 | 2,892 | $786,756 | $202,553 |
| 2021 | 20 | 2,219 | 2,745 | $821,001 | $214,484 |
| 2020 | 18 | 2,018 | 2,386 | $726,323 | $173,050 |
Total Patients
9,054
Total Services
10,971
Medicare Billing
$785,392
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 714 | 1,093 | $244,957 | $80,065 | 32.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 59 | 72 | $154,656 | $33,752 | 21.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 123 | 123 | $128,043 | $25,082 | 19.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 46 | 46 | $64,676 | $13,171 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $34,960 | $8,842 | 25.3% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $26,502 | $5,137 | 19.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 91 | 91 | $21,749 | $4,842 | 22.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 679 | 770 | $24,640 | $4,834 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 36 | $13,320 | $3,941 | 29.6% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 53 | 54 | $18,144 | $3,346 | 18.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $17,499 | $3,196 | 18.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 231 | 236 | $9,912 | $2,545 | 25.7% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 14 | 15 | $7,590 | $1,618 | 21.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 78 | 79 | $7,347 | $1,579 | 21.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 22 | 22 | $5,258 | $1,009 | 19.2% |
| 93572 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | Facility | 2023 | 18 | 20 | $3,940 | $900.60 | 22.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $3,336 | $834.98 | 25.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 72 | 73 | $2,044 | $429.12 | 21.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 73 | 74 | $1,036 | $181.77 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 681 | 1,089 | $216,534 | $79,550 | 36.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 62 | 69 | $148,212 | $34,092 | 23.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 124 | 126 | $131,166 | $25,658 | 19.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 45 | 45 | $63,270 | $13,471 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $28,177 | $7,710 | 27.4% |
| 92943 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | Facility | 2022 | 14 | 14 | $33,754 | $6,378 | 18.9% |
About Dr. Thomas Mayer, MD
Dr. Thomas Mayer, MD is a Internal Medicine healthcare provider based in Bannockburn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013937150.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mayer, MD has received a total of $132,142 in payments from pharmaceutical and medical device companies, with $4,230 received in 2024. These payments were reported across 858 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,350).
As a Medicare-enrolled provider, Mayer has provided services to 9,054 Medicare beneficiaries, totaling 10,971 services with total Medicare billing of $785,392. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Bannockburn, IL
- Active Since 07/20/2006
- Last Updated 10/06/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013937150
Products in Payments
- XARELTO (Drug) $41,831
- ENTRESTO (Drug) $27,276
- ELIQUIS (Drug) $15,942
- FARXIGA (Drug) $12,189
- Repatha (Biological) $11,269
- Endeavor (Device) $4,336
- Ozempic (Drug) $1,125
- LEQVIO (Drug) $1,117
- JARDIANCE (Drug) $1,116
- WATCHMAN (Device) $1,072
- BRILINTA (Drug) $1,067
- Coronary Orbital Atherectomy System (Device) $992.12
- Impella (Device) $952.72
- Corlanor (Drug) $900.92
- LifeVest (Device) $886.03
- Asahi Fielder coronary guide wire (Device) $867.04
- LINQ II (Device) $584.66
- OPSUMIT (Drug) $496.74
- PRADAXA (Drug) $490.19
- Optis Coronary Imaging System (Device) $490.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bannockburn
David Davidson, Md, MD
Internal Medicine — Payments: $259,583
Internal Medicine $259,583
Dr. Adam Silver, Md, MD
Internal Medicine — Payments: $6,844
Internal Medicine $6,844
Dr. Brent Nathan, Md, MD
Internal Medicine — Payments: $692.26
Internal Medicine $692.26
Deepanjali Jain, Md, MD
Internal Medicine — Payments: $513.10
Internal Medicine $513.10
Dr. Larry Kaskel, Md, MD
Internal Medicine — Payments: $509.12
Internal Medicine $509.12
Sabrina Jones, M.d, M.D
Internal Medicine — Payments: $476.03
Internal Medicine $476.03